MedTrace Logo

GEBT Telehealth Administration Usability Study

NCT04684992 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2021-08-24

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to establish the usability of a telehealth platform for the administration of GEBT.

Conditions

Interventions

DEVICE

GEBT Telehealth Administration Usability

Establish the usability of a telehealth platform for the administration of GEBT

Sponsors & Collaborators

  • Cairn Diagnostics

    lead INDUSTRY

Principal Investigators

  • Alex Ryder, MD, PhD · Cairn Diagnostics

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-11
Primary Completion
2021-03-10
Completion
2021-03-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04684992 on ClinicalTrials.gov